Cargando…

Human Pluripotent Stem-Cell-Derived Models as a Missing Link in Drug Discovery and Development

Human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and human-induced pluripotent stem cells (hiPSCs), have the potential to accelerate the drug discovery and development process. In this review, by analyzing each stage of the drug discovery and development process, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Xiying, Tang, Jiayu, Lou, Yan-Ru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230131/ https://www.ncbi.nlm.nih.gov/pubmed/34070895 http://dx.doi.org/10.3390/ph14060525

Ejemplares similares

Challenges for the Applications of Human Pluripotent Stem Cell-Derived Liver Organoids
por: Chang, Mingyang, et al.
Publicado: (2021)

Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery
por: Tricot, Tine, et al.
Publicado: (2022)

Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery
por: Huang, Juan, et al.
Publicado: (2021)

Translational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug Discovery
por: Hosoya, Masaki, et al.
Publicado: (2016)

Contribution of Human Pluripotent Stem Cell-Based Models to Drug Discovery for Neurological Disorders
por: Benchoua, Alexandra, et al.
Publicado: (2021)

Accurate nanoelectrode recording of human pluripotent stem cell-derived cardiomyocytes for assaying drugs and modeling disease
por: Lin, Ziliang Carter, et al.
Publicado: (2017)

Somatostatin signalling promotes the differentiation of rod photoreceptors in human pluripotent stem cell‐derived retinal organoid
por: Chen, Mingkang, et al.
Publicado: (2022)

Human Pluripotent Stem Cells for Modeling of Anticancer Therapy-Induced Cardiotoxicity and Cardioprotective Drug Discovery
por: Keung, Wendy, et al.
Publicado: (2021)

Development and Characterization of Human Induced Pluripotent Stem Cell-Derived Cholangiocytes
por: De Assuncao, Thiago M., et al.
Publicado: (2015)

Thyroid Hormone Effect on the Differentiation of Human Induced Pluripotent Stem Cells into Hepatocyte-Like Cells
por: Bogacheva, Mariia S., et al.
Publicado: (2021)

Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery
por: Jang, Jiho, et al.
Publicado: (2012)

Drug Discovery via Human-Derived Stem Cell Organoids
por: Liu, Fangkun, et al.
Publicado: (2016)

Linking Incomplete Reprogramming to the Improved Pluripotency of Murine Embryonal Carcinoma Cell-Derived Pluripotent Stem Cells
por: Chang, Gang, et al.
Publicado: (2010)

Drug Discovery Models and Toxicity Testing Using Embryonic and Induced Pluripotent Stem-Cell-Derived Cardiac and Neuronal Cells
por: Deshmukh, Rahul S., et al.
Publicado: (2012)

Discovery and characterization of variance QTLs in human induced pluripotent stem cells
por: Sarkar, Abhishek K., et al.
Publicado: (2019)

Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives
por: Chow, Maggie Zi, et al.
Publicado: (2013)

Optimized protocol for analysis of neural stem proliferation in human-pluripotent-stem-cell-derived cerebral organoids
por: Tang, Xiao-Yan, et al.
Publicado: (2023)

Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery
por: De Masi, Claudia, et al.
Publicado: (2020)

Use of Human Pluripotent Stem Cells to Define Initiating Molecular Mechanisms of Cataract for Anti-Cataract Drug Discovery
por: Dewi, Chitra Umala, et al.
Publicado: (2019)

Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery
por: Singh, Vimal K., et al.
Publicado: (2015)

Pluripotent Stem Cells in Disease Modeling and Drug Discovery for Myotonic Dystrophy Type 1
por: Bérenger-Currias, Noémie, et al.
Publicado: (2023)

Derivation of new pluripotent stem cells from human extended pluripotent stem cells with formative features and trophectoderm potential
por: Zhu, Pinmou, et al.
Publicado: (2023)

Downstream bioprocessing of human pluripotent stem cell‐derived therapeutics
por: Sart, Sebastien, et al.
Publicado: (2021)

Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and Safety
por: Meseguer-Ripolles, Jose, et al.
Publicado: (2017)

Generation of intestinal organoids derived from human pluripotent stem cells for drug testing
por: Yoshida, Shinpei, et al.
Publicado: (2020)

Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity
por: Schwach, Verena, et al.
Publicado: (2020)

Modeling human development and disease in pluripotent stem cell-derived gastric organoids
por: McCracken, Kyle W., et al.
Publicado: (2014)

Early‐stage development of human induced pluripotent stem cell‐derived neurons
por: Ohara, Yuki, et al.
Publicado: (2015)

Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells
por: Galat, Vasiliy, et al.
Publicado: (2016)

Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening
por: Ovics, Paz, et al.
Publicado: (2020)

Induced Pluripotent Stem Cells: A Powerful Neurodegenerative Disease Modeling Tool for Mechanism Study and Drug Discovery
por: Chang, Chia-Yu, et al.
Publicado: (2018)

A Novel High-Content Screening-Based Method for Anti-Trypanosoma cruzi Drug Discovery Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Portella, Diogo Crispim Nascimento, et al.
Publicado: (2021)

Pluripotent stem cells for pathological modelling of Hutchinson-Gilford Progeria Syndrome (HGPS) and drug discovery
por: Nissan, Xavier
Publicado: (2015)

Patient and Disease–Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics
por: Paik, David T., et al.
Publicado: (2020)

Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Niemann-Pick Type C1
por: Völkner, Christin, et al.
Publicado: (2021)

Insights Into Human Development and Disease From Human Pluripotent Stem Cell Derived Intestinal Organoids
por: Daoud, Abdelkader, et al.
Publicado: (2019)

Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation
por: Sampaziotis, Fotios, et al.
Publicado: (2015)

Human pluripotent stem-cell-derived alveolar organoids for modeling pulmonary fibrosis and drug testing
por: Kim, Jung-Hyun, et al.
Publicado: (2021)

Modelling X-linked Alport Syndrome With Induced Pluripotent Stem Cell-Derived Podocytes
por: Lau, Ricky Wai Kiu, et al.
Publicado: (2021)

In vitro patterning of pluripotent stem cell-derived intestine recapitulates in vivo human development
por: Tsai, Yu-Hwai, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_220be702js0m8k109acfklgc9i